{
    "clinical_study": {
        "@rank": "30032", 
        "arm_group": {
            "arm_group_label": "Diagnostic (PET-CT and PET-MRI)", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergo fludeoxyglucose F 18 PET-CT and PET-MRI."
        }, 
        "brief_summary": {
            "textblock": "This pilot clinical trial studies positron emission tomography (PET)-magnetic resonance\n      imaging (MRI) and PET-computed tomography (CT) as diagnostic imaging in patients with colon\n      and/or rectal cancer. New diagnostic imaging procedures, such as PET-MRI, may help find and\n      diagnose rectal cancer or recurrence of colorectal cancer"
        }, 
        "brief_title": "PET-MRI in Diagnosing Patients With Colon or Rectal Cancer", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Recurrent Colon Cancer", 
            "Recurrent Rectal Cancer", 
            "Stage IIA Colon Cancer", 
            "Stage IIA Rectal Cancer", 
            "Stage IIB Colon Cancer", 
            "Stage IIB Rectal Cancer", 
            "Stage IIC Colon Cancer", 
            "Stage IIC Rectal Cancer", 
            "Stage IIIA Colon Cancer", 
            "Stage IIIA Rectal Cancer", 
            "Stage IIIB Colon Cancer", 
            "Stage IIIB Rectal Cancer", 
            "Stage IIIC Colon Cancer", 
            "Stage IIIC Rectal Cancer", 
            "Stage IVA Colon Cancer", 
            "Stage IVA Rectal Cancer", 
            "Stage IVB Colon Cancer", 
            "Stage IVB Rectal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Colonic Neoplasms", 
                "Rectal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To test the diagnostic performance of PET- MRI in the staging of preoperative high-grade\n      rectal cancer patients, defined by T3 stage or higher or N1 stage or higher or presence of\n      metastasis, that are referred to PET-CT and MRI.\n\n      II. To test the diagnostic performance of PET-MRI the follow up of colorectal cancer\n      patients that are referred to PET-CT with or without a diagnostic MRI request by their\n      physicians.\n\n      SECONDARY OBJECTIVES:\n\n      I. To test different attenuation correction MR sequences and novel diagnostic MR sequences.\n\n      OUTLINE:\n\n      Patients undergo fludeoxyglucose F 18 PET-CT and PET-MRI."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Either having a T3 (the cancer has grown through the muscularis propria and into the\n             outermost layers of the colon or rectum but not through them) or higher, node\n             positivity or metastatic lesion in the context of rectal cancer or being studied for\n             colorectal cancer follow up, independent of the renal function\n\n          -  PET-CT should be requested by a referring physician; in the case of having an MR\n             requested as well, it will be reported from the MRI images generated in the PET-MRI\n\n          -  Stable physical medical conditions to undergo a MRI\n\n          -  Informed consent must be given and signed prior to study enrollment\n\n        Exclusion Criteria:\n\n          -  Refuse to give and/or sign the informed consent\n\n          -  Subjects who do not meet the above mentioned inclusion criteria\n\n          -  Subjects who have a pacemaker\n\n          -  Subjects who have a metallic prostheses either in the pelvis or in the abdomen that\n             will interfere with the MR imaging of that anatomical area\n\n          -  Subjects who suffer from claustrophobia\n\n          -  Pregnant women\n\n          -  Cognitive impairment that affects the subject's ability to give consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01807117", 
            "org_study_id": "CASE8212", 
            "secondary_id": "NCI-2013-00511"
        }, 
        "intervention": [
            {
                "arm_group_label": "Diagnostic (PET-CT and PET-MRI)", 
                "description": "Undergo fludeoxyglucose F 18 PET-CT and PET-MRI", 
                "intervention_name": "positron emission tomography", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "FDG-PET", 
                    "PET", 
                    "PET scan", 
                    "tomography, emission computed"
                ]
            }, 
            {
                "arm_group_label": "Diagnostic (PET-CT and PET-MRI)", 
                "description": "Undergo fludeoxyglucose F 18 PET-CT and PET-MRI", 
                "intervention_name": "computed tomography", 
                "intervention_type": "Procedure", 
                "other_name": "tomography, computed"
            }, 
            {
                "arm_group_label": "Diagnostic (PET-CT and PET-MRI)", 
                "description": "Undergo fludeoxyglucose F 18 PET-CT and PET-MRI", 
                "intervention_name": "magnetic resonance imaging", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "MRI", 
                    "NMR imaging", 
                    "NMRI", 
                    "nuclear magnetic resonance imaging"
                ]
            }, 
            {
                "arm_group_label": "Diagnostic (PET-CT and PET-MRI)", 
                "description": "Undergo fludeoxyglucose F 18 PET-CT and PET-MRI", 
                "intervention_name": "fludeoxyglucose F 18", 
                "intervention_type": "Radiation", 
                "other_name": [
                    "18FDG", 
                    "FDG"
                ]
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "contact": {
                "email": "Raj.Paspulati@UHhospitals.org", 
                "last_name": "Raj Paspulati", 
                "phone": "216-844-1542"
            }, 
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44106-5065"
                }, 
                "name": "Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center"
            }, 
            "investigator": {
                "last_name": "Raj Paspulati", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of PET-MRI in Initial Staging of High Grade Rectal Cancer Patients and in the Follow up of Colorectal Cancer Patients.", 
        "overall_official": {
            "affiliation": "Case Comprehensive Cancer Center", 
            "last_name": "Raj Paspulati, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Calculated with its 95% confidence interval using the standard formulas according to the criterion standard. Continuous variables will be expressed as mean and standard deviation. Comparisons between continuous variables will be performed by using the Student t test. Comparisons between qualitative variables will be performed by using the chi-square test with the Yates' correction or McNemar's test as appropriate.", 
                "measure": "Sensitivity for PET-CT and PET-MRI", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Calculated with its 95% confidence interval using the standard formulas according to the criterion standard. Continuous variables will be expressed as mean and standard deviation. Comparisons between continuous variables will be performed by using the Student t test. Comparisons between qualitative variables will be performed by using the chi-square test with the Yates' correction or McNemar's test as appropriate.", 
                "measure": "Specificity for PET-CT and PET-MRI", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Calculated with its 95% confidence interval using the standard formulas according to the criterion standard. Continuous variables will be expressed as mean and standard deviation. Comparisons between continuous variables will be performed by using the Student t test. Comparisons between qualitative variables will be performed by using the chi-square test with the Yates' correction or McNemar's test as appropriate.", 
                "measure": "Positive and negative predictive values for PET-CT and PET-MRI", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Calculated with its 95% confidence interval using the standard formulas according to the criterion standard. Continuous variables will be expressed as mean and standard deviation. Comparisons between continuous variables will be performed by using the Student t test. Comparisons between qualitative variables will be performed by using the chi-square test with the Yates' correction or McNemar's test as appropriate.", 
                "measure": "Accuracy for PET-CT and PET-MRI", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01807117"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Case Comprehensive Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Case Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}